Hypoglycemic effect of cleome droserifolia ethanolic leaf extract in experimental diabetes, and on non-enzymatic antioxidant, glycogen, thyroid hormone and insulin levels

Diabetologia Croatica

Volumn 35, Issue 1, 2006, Pages 15-22

  El Shenawy, Nahla S ^a   Abdel Nabi, Ismail M ^a  

^a Suez Canal University   (Egypt)

Author keywords

Antioxidant; Biochemical aspects; Cleome droserifolia; Diabetes mellitus

Indexed keywords

ALBUMIN; ALCOHOL; ALLOXAN; ALPHA GLOBULIN; ANTIOXIDANT; BETA GLOBULIN; CLEOME DROSERIFOLIA EXTRACT; GLUCOSE; GLUTATHIONE; GLYCOGEN; INSULIN; PLANT EXTRACT; THYROID HORMONE; URIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLEOME; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; GLUCOSE BLOOD LEVEL; GLYCOGEN ANALYSIS; INSULIN RELEASE; INSULIN RESISTANCE; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS;

EID: 33845569751     PISSN: 03510042     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Vats V, Yadav SP, Grover JK. Ethanolic extract of Ocimum sanctum leaves partially attenuates streptozotocin-induced alterations in glycogen content and carbohydrate metabolism in rats. J Ethnopharmacol 2004;90:155-160.
2. Boulos L. Flora of Egypt; Azollaceae-Oxalidaceae, Vol 1. Cairo: Al-Hadara, 1999; p. 170.
3. Ismael LD. Pharmacognostical study of certain Cleome species growing in Egypt. Master of Science thesis. Faculty of Pharmacology, Al-Azhar University, 1992.
4. Nicola WG, Ibrahim KM, Mikhail TH, et al. Role of the hypoglycemic plant extract Cleome droserifolia in improving glucose and lipid metabolism and its relation to insulin resistance in fatty liver. Boll Chim Farm 1996;135:507-551.
5. Fushiya S, Kishi Y, Hattori K, et al. Flavonoids from Cleome droserifolia suppress NO production in activated macrophages in vitro. Planta Med 1999;65:404-407.
6. El-Shenawy NS, Abdel Nabi IM. Comparative analysis of the protective effect of melatonin and Cleome droserifolia extract on antioxidant status of diabetic rats. Egypt J Hosp Med 2004;14:11-25.
7. Egyptian Pharmacopoeia, Vol. 2. Cairo: Cairo Organization for Government Printing Office, 1984; p. 1158.
8. Benny K, Braham A, Adithan C. Review of endocrine pharmacology. Indian J Pharmacol 2000;32:S67-S80.
9. Sanford HS. Method for obtaining venous blood from the orbital sinus of the rat or mouse. Science 1954;119:100.
10. Huistijn M, De Oliveira RMF, De Moura EG, et al. Lower faecal egg excretion in chemically-induced diabetic mice infected with Schistosoma mansoni due to impaired egg maturation. Mem Inst Oswaldo Cruz 2001;6:393-396.
11. Minzhu C. Experimental methods of corticoids and its antagonists. In: Shuyun X, Rulian B, eds, Methodology of pharmacological experiments. Beijing: The People's Medical Publishing House, 1994. p. 1246-1260.
12. Rand TL, Murray RK. Plasma protein, immunoglobulins, and blood coagulation. In: Murray RK, Granner DK, Mayes PA, Rodwell VW, eds. Harper's biochemistry. New Jersey; 1999: p. 737-739.
13. Beutler E, Duron O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med 1963;61:882-888.
14. Fossati P, Prencipe L, Berti G. Use of 3,5-dichloro-2- hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine. Clin Chem 1980;26:227-231.
15. Chopra IJ, Solomon DH, Ho RS. A radioimmunoassay of thyroxin. J Clin Endocrinol 1971;33:865-868.
16. Liewendahl K. Assessment of thyroid status by laboratory methods: developments and perspectives. J Clin Lab Invest 1990;201:83-92.
17. Starr JI, Mako ME, Juhn D, et al. Measurement of serum proinsulin-like material: cross-reactivity of porcine and human proinsulin in the insulin radioimmunoassay. J Lab Clin Med 1978;91:691-692.
18. th ed. Philadelphia: WB Saunders, 2000: p. 810-818.
19. Junod A, Lambert AE, Stauffacher, W. Diabetogenic action of streptozotocin: relationship of dose to metabolic response. J Clin Invest 1969;48:2129-2139.
20. Grover JK, Vats V, Rathi SS. Anti-hyperglycemic effects of Eugenia jambolana and Tinospora cordifolia in experimental diabetes and their effects on key metabolic enzymes involved in carbohydrate metabolism. J Ethnopharmacol 2000;73:461-470.
21. Yang SS, Mabry TJ, El-Fishawy T, et al. Flavonoids of Cleome droserifolia (Forssk) Del. Egypt J Pharm Sci 1990;31:343-351.
22. Abdel-Moneim A, El-Feki M, Salh E. Effect of Nigella sativa, fish oil and gliclazide on alloxan diabetic rats. 1- Biochemical and histopathological studies. J Egypt Ger 1997;23:237-265.
23. Annamala PT, Augusti KT. Studies on the biochemical effect of glibenclamide on alloxan diabetic rabbit. Experientia 1980;36:383-384.
24. st ed. Boston Portala Valet: Jones and Bart Wett Publishers, 1990: p. 368-369.
25. William FG. Circulating blood fluid. In: Review of medical physiology. Lebanon: McGraw-Hill Company, Inc., 2001. p. 522-524.
26. Ohkuwa T, Sato Y, Naoi M. Hydroxyl radical formation in diabetogenic rats induced by streptozotocin. Life Sci 1995;56:1789-1795.
27. Soon YY, Tan BKH. Evaluation of the hypoglycemic and anti-oxidant activities of Morinda officinalis in streptozotocin-induced diabetic rats. Singapore Med J 2002;43:77-85.
28. Kakkar R, Mantha SV, Radhi J, et al. Increased oxidative stress in rat liver and pancreas during progression of streptozotocin-induced diabetes. Clin Sci London 1998;94:623-632.
29. Bonnefont-Rousselot D, Bastard JP, Jaudon MC, et al. Consequences of the diabetic status on the oxidant/antioxidant balance. Diabet Metab 2000;26:163-176.
30. Szkudelski T, Kandulska K, Okulicz M. Alloxan in vivo does not only exert deleterious effects on pancreatic B cells. Physiol Res 1998;47:343-346.
31. Sharma MK, Buetner GR. Interaction of vitamin C and vitamin E during free radical stress in plasma. Free Radic Biol Med 1993;14:649-653.
32. Itoh S, Yamagishi F, Matsuyama Y. Relationship between liver microsomal function and serum thyroid hormones in rats treated with carbon tetrachloride. Res Commun Mol Pathol Pharmacol 1989;65:111-114.
33. Sambandam N, Abraham MA, Craig S, Al-Atar O, et al. Metabolism of VLDL is increased in streptozotocin-induced diabetic rat hearts. Am J Physiol 2000;278:H1874-1882.
34. Baynes JW. Reactive oxygen in the etiology and complications of diabetes. In: Ioannides G, Flatt PR, eds. Drug, diet and disease, Vol. 2. Mechanistic approach to diabetes. Hertfordshire: Ellis Horwood Ltd., 1995: p. 203-231.